Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors
Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors
Recruiting · NCT06612645 · Registry updated 2026-03-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors | Pediatric Cancers; Solid Tumor Pediatric | Recruiting | Phase 1 | 2026-03-02 | NCT06612645 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chulalongkorn University | 53 |
| King Chulalongkorn Memorial Hospital | 19 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| King Chulalongkorn Memorial Hospital | Bangkok | Thailand | 5 |